text size: T | T
Back to Snapshot
Company Description

Contact Info

One Bridge Plaza

Fort Lee, NJ 07024

United States

Phone: 201-592-6451

Fax: 201-592-0366

Neurologix, Inc., a development stage company, engages in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other therapies. The company’s development activities are focused on gene transfer for treating Parkinson’s disease. Its technology, referred to as ‘NLX,’ is in the clinical development stages, was tested in a Phase 1 and Phase 2 clinical trials to treat Parkinson’s disease. The company intends to continue to develop therapies to treat other neurodegenerative and metabolic disorders, including clinical testing for its therapy relating to Huntington’s disease. Agreements The company has a license agreement with Aegera Therapeutics Inc. whereby it was granted a license for the worldwide rights, excluding China, for the use of dXIAP for therapeutic or prophylactic purposes in the treatment of Huntington’s disease. In 2009, the company entered into a license agreement with Cornell University (Cornell), whereby Cornell granted it a license for the worldwide use of certain patents for the development of products and methods for the treatment of psychiatric conditions. History Neurologix, Inc. was founded in 1999.


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

NRGXQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NRGXQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation NRGXQ Industry Range
No financial data is available for NRGXQ.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEUROLOGIX INC, please visit www.neurologix.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.